Clinical Trial Update: Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

The document reports completion of a Phase 1 trial evaluating selumetinib in combination with cyclosporine for advanced solid tumors or advanced/metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Solid Tumors

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Selumetinib (selumetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colorectal Carcinoma, Solid Neoplasm | Phase 1 | Status: COMPLETED